ArticleStructural heart : the journal of the Heart Team2026
Effect of Age on Short-Term Readmissions Following Transcatheter Edge-to-Edge Repair of the Mitral Valve.
Article in Structural heart : the journal of the Heart Team, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As transcatheter edge-to-edge repair (TEER) is increasingly used in younger and older patients, there is a need to investigate outcomes across all age groups. We investigated age as a risk factor for short-term readmission after transcatheter mitral valve TEER. Methods: We reviewed the National Readmission Database for 2018-2022 to identify patients undergoing TEER and stratified patients into three age groups (<65, 65-80, and >80 years [years]) to compare odds of 30-day and 90-day overall readmissions and heart failure readmissions using logistic regression. Results: Thirty- and 90-day cohorts included 25,648 and 20,586 persons with overall readmission rates of 14.7% and 27.8%, respectively. Compared to those <65 years, the adjusted 30-day odds ratio was 0.91 (95% confidence interval [CI], 0.72-1.16; Conclusions: With similar event rates between older and younger patients, age was not a significant predictor of readmission following TEER at 30 or 90 days. These findings suggest that TEER may offer benefit across age groups among individuals with moderate to severe mitral regurgitation. The higher proportion of stroke-related readmissions observed among older patients highlights an urgent need for improved risk stratification strategies tailored for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.